Star Health and Allied Insurance has drawn renewed attention from market participants following its Q4 FY25 earnings release and forward-looking commentary.

In its latest equity research note, Motilal Oswal has reaffirmed its BUY recommendation on Star Health and Allied Insurance with a revised target price of Rs 460, reflecting an 18% upside from the

Health insurance stocks experienced significant gains in today's trade, following a series of GST reduction proposals put forward by the Group of Ministers (GoM) on rate rationalization.

Indian markets were trading slightly higher on Monday but stock specific action has been keeping traders busy.

Market expert Varun Dubey has suggested four BUY Calls and no SELL Call for short term investors and traders.